Table 3.
Demographic profile, previous rheumatic diseases, and previous treatment in patients with CHIKA followed after the end of treatment
| Prior treatment to chikungunya arthritis | N (%) |
|---|---|
| Number of patients | 123 |
| Age (years) | |
| Mean ± SD | 58.5 ± 13.8 |
| Median | 58.0 |
| Female | 110 (89.4) |
| Time between the end of treatment and telephone contact (months) | |
| Mean ± SD | 4.7 ± 0.8 |
| Prior treatment for chikungunya arthritis | |
| Corticosteroids | 73 (59.3) |
| Acetaminophen or dipyrone | 78 (63.4) |
| Pregabalin, codeine, or tramadol | 17 (13.8) |
| NSAIDs | 6 (4.8) |
| DMARDs (MTX) | 1 (0.81) |
| Previous reported rheumatic diseases | |
| Osteoarthritis | 26 (21.1) |
| Osteoporosis | 11 (8.9) |
| Tendinitis/bursitis | 6 (4.8) |
| Fibromyalgia | 4 (3.2) |
| Rheumatoid arthritis | 2 (1.6) |
| Rheumatic fever | 1 (0.8) |
CHIKA = chikungunya arthritis; DMARD = disease-modifying antirheumatic drug; MTX = methotrexate; NSAID = nonsteroidal anti-inflammatory drug.